Financial Lp Hrt Sells 85,317 Shares of NewGenIvf Group (NASDAQ:NIVF) Stock

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt sold 85,317 shares of the stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $0.80, for a total transaction of $68,253.60. Following the transaction, the insider owned 54,561 shares of the company’s stock, valued at approximately $43,648.80. This represents a 60.99% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Tuesday, May 26th, Financial Lp Hrt acquired 27,993 shares of NewGenIvf Group stock. The shares were acquired at an average price of $0.92 per share, with a total value of $25,753.56.
• On Friday, May 22nd, Financial Lp Hrt acquired 137,541 shares of NewGenIvf Group stock. The shares were acquired at an average price of $0.99 per share, with a total value of $136,165.59.

NewGenIvf Group Price Performance

NewGenIvf Group stock opened at $0.91 on Friday. The firm has a 50-day moving average of $1.65 and a 200-day moving average of $6.70. NewGenIvf Group Limited has a one year low of $0.72 and a one year high of $1,839.00. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12.

NewGenIvf Group (NASDAQ:NIVF) last issued its earnings results on Tuesday, March 31st. The company reported ($287.24) earnings per share (EPS) for the quarter. The company had revenue of $1.42 million for the quarter. On average, equities analysts anticipate that NewGenIvf Group Limited will post 4.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Monday, April 27th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.